Robert Bruce Cuts Abbott Laboratories Holdings by 14.95% at $127.30
Robert Bruce reduced Abbott Laboratories holdings by 20,000 shares in Q4 2025, a 14.95% decline at an average $127.30 per share. Abbott stock returned -12.39% over three months and -9.61% year-to-date, and the cut shaved 0.83% off his portfolio.
1. Portfolio Adjustment Details
Robert Bruce reduced Abbott Laboratories holdings by 20,000 shares in the fourth quarter of 2025, marking a 14.95% decrease at an average price of $127.30 per share and trimming 0.83% from his portfolio weight.
2. Abbott Laboratories Performance
Abbott Laboratories shares have declined 12.39% over the past three months and 9.61% year-to-date, reflecting recent market challenges and influencing Bruce’s decision to scale back the position.
3. Bruce & Co Fund Overview
The Bruce Fund holds a diversified mix of small-, mid-, and select large-cap equity, along with distressed debt and government securities, currently comprising 39 stocks with top sector allocations in healthcare, utilities, and financial services.